| CircHIPK3/miR-124 affects angiogenesis in early-onset preeclampsia via CPT1A-mediated fatty acid oxidation. | CircHIPK3/miR-124 affects angiogenesis in early-onset preeclampsia via CPT1A-mediated fatty acid oxidation.
Wu Y, Huang J, Liu L, Zhang X, Zhang W, Li Q. | 07/25/2024 |
| miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression. | miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression.
Wang C, Fu R, Wang Y, Wei J, Yu Y, Hu L, Zhang C., Free PMC Article | 07/19/2024 |
| MicroRNA-124 influenced depressive symptoms via large-scale brain connectivity in major depressive disorder patients. | MicroRNA-124 influenced depressive symptoms via large-scale brain connectivity in major depressive disorder patients.
He C, Wang Q, Fan D, Liu X, Bai Y, Zhang H, Zhang H, Yao H, Zhang Z, Xie C. | 07/3/2024 |
| MiR-124-3p negatively impacts embryo implantation via suppressing uterine receptivity formation and embryo development. | MiR-124-3p negatively impacts embryo implantation via suppressing uterine receptivity formation and embryo development.
Yao K, Kang Q, Chen K, Shi B, Jin X., Free PMC Article | 06/25/2024 |
| MALAT1 as a potential salivary biomarker in oral squamous cell carcinoma through targeting miRNA-124. | MALAT1 as a potential salivary biomarker in oral squamous cell carcinoma through targeting miRNA-124.
Shalaby R, Ibrahim S, Kotb AAW, Baz S, Hafed L, Shaker O, Afifi S. | 06/14/2024 |
| Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington's disease. | Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington's disease.
Kim KH, Hong EP, Lee Y, McLean ZL, Elezi E, Lee R, Kwak S, McAllister B, Massey TH, Lobanov S, Holmans P, Orth M, Ciosi M, Monckton DG, Long JD, Lucente D, Wheeler VC, MacDonald ME, Gusella JF, Lee JM., Free PMC Article | 04/17/2024 |
| The relationship between DNA methyltransferase 3B (DNMT3B) and miR 124-3pa expressions in bladder cancer tissues. | The relationship between DNA methyltransferase 3B (DNMT3B) and miR 124-3pa expressions in bladder cancer tissues.
Fawzy MS, El Faiomy ARM, El Desoky AMZ, Hussein S. | 11/30/2023 |
| Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p/ITGB1 axis. | Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p/ITGB1 axis.
Xia W, Chen X, Zhu Z, Chen H, Li B, Wang K, Huang L, Liu Z, Chen Z., Free PMC Article | 11/1/2023 |
| METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma. | METTL3-modified lncRNA-MALAT1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma.
He F, Ren T, Tang X. | 08/25/2023 |
| miR-124-3p regulates the proliferation and differentiation of retinal progenitor cells through SEPT10. | miR-124-3p regulates the proliferation and differentiation of retinal progenitor cells through SEPT10.
Shen B, Gao H, Zhang D, Yu H, Chen J, Huang S, Gu P, Zhong Y. | 06/5/2023 |
| Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway. | Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway.
Zhao X, Xu M, Hu X, Ding X, Zhang X, Xu L, Li L, Sun X, Song J., Free PMC Article | 06/2/2023 |
| MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2. | MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2.
Song BF, Xu LZ, Jiang K, Cheng F., Free PMC Article | 03/10/2023 |
| HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway. | HRCT1, negatively regulated by miR-124-3p, promotes tumor metastasis and the growth of gastric cancer by activating the ERBB2-MAPK pathway.
Hou F, Shi DB, Guo XY, Zhao RN, Zhang H, Ma RR, He JY, Gao P. | 02/28/2023 |
| miR-124-3p mediates polygenic risk shared between schizophrenia and bipolar disorder. | miR-124-3p mediates polygenic risk shared between schizophrenia and bipolar disorder.
Żurawek D, Turecki G. | 01/28/2023 |
| Increased miR-124-3p alleviates type 2 inflammatory response in allergic rhinitis via IL-4Ralpha. | Increased miR-124-3p alleviates type 2 inflammatory response in allergic rhinitis via IL-4Rα.
Liu Q, Shen Y, Xiao Y, Xiang H, Chu L, Wang T, Liu H, Tan G., Free PMC Article | 11/5/2022 |
| Multiple knockout mouse and embryonic stem cell models reveal the role of miR-124a in neuronal maturation. | Multiple knockout mouse and embryonic stem cell models reveal the role of miR-124a in neuronal maturation.
Chaya T, Maeda Y, Sugimura R, Okuzaki D, Watanabe S, Varner LR, Motooka D, Gyoten D, Yamamoto H, Kato H, Furukawa T., Free PMC Article | 10/22/2022 |
| Novel microRNA biomarkers of systemic lupus erythematosus in plasma: miR-124-3p and miR-377-3p. | Novel microRNA biomarkers of systemic lupus erythematosus in plasma: miR-124-3p and miR-377-3p.
Yan L, Jiang L, Wang B, Hu Q, Deng S, Huang J, Sun X, Zhang Y, Feng L, Chen W. | 08/20/2022 |
| EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA. | EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA.
Shuang O, Zhou J, Cai Z, Liao L, Wang Y, Wang W, Xu M., Free PMC Article | 07/2/2022 |
| MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon. | MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon.
Sun TY, Li YQ, Zhao FQ, Sun HM, Gao Y, Wu B, Yang S, Ji FQ, Zhou DS., Free PMC Article | 05/21/2022 |
| Roles of miR-124-3p/Scd1 in urolithin A-induced brown adipocyte differentiation and succinate-dependent regulation of mitochondrial complex II. | Roles of miR-124-3p/Scd1 in urolithin A-induced brown adipocyte differentiation and succinate-dependent regulation of mitochondrial complex II.
Li Q, Wang L, Liu H, Ren W, Zhang Z, Xia B. | 05/7/2022 |
| MicroRNA miR-124-3p suppresses proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1). | MicroRNA miR-124-3p suppresses proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1).
Zhao Q, Jiang F, Zhuang H, Chu Y, Zhang F, Wang C., Free PMC Article | 05/7/2022 |
| Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism. | Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
Shen Z, Wu Y, He G., Free PMC Article | 05/7/2022 |
| MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1. | MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1.
Dong ZB, Wu HM, He YC, Huang ZT, Weng YH, Li H, Liang C, Yu WM, Chen W., Free PMC Article | 03/26/2022 |
| MicroRNA-124 acts as a positive regulator of IFN-beta signaling in the lipopolysaccharide-stimulated human microglial cells. | MicroRNA-124 acts as a positive regulator of IFN-β signaling in the lipopolysaccharide-stimulated human microglial cells.
Pajarskienė J, Kašėta V, Vaikšnoraitė K, Tunaitis V, Pivoriūnas A. | 03/12/2022 |
| MicroRNAs sequencing of plasma exosomes derived from patients with atrial fibrillation: miR-124-3p promotes cardiac fibroblast activation and proliferation by regulating AXIN1. | MicroRNAs sequencing of plasma exosomes derived from patients with atrial fibrillation: miR-124-3p promotes cardiac fibroblast activation and proliferation by regulating AXIN1.
Zhu P, Li H, Zhang A, Li Z, Zhang Y, Ren M, Zhang Y, Hou Y. | 03/5/2022 |